13.3 Immune System Function & Lymphatic Pathologies

Immune System Function & Lymphatic Pathologies

Core Concept: The human immune system is a complex, distributed physiological defense network comprising cells, circulating humoral proteins, and signaling cytokines. It is structured into two collaborative arms: non-specific innate immunity, which mounts immediate resistance against generic microbial structures, and antigen-specific adaptive immunity, which deploys targeted clonal responses and generates immunological memory.

1. Overview of Immunity: Innate vs. Adaptive Paradigms

Immunity represents the body's capacity to resist and neutralize pathogenic microorganisms (bacteria, viruses, fungi, parasites), foreign toxic macromolecules, and malignant neoplastic cells:

Immune System Structural Organization:
┌───────────────────────────────────────────────────────────────────────────────┐
│ INNATE IMMUNITY (Non-Specific / Inborn)                                       │
│ • First Line of Defense:  Intact Skin, Acid Mantle, Mucosa, Cilia, Lysozyme  │
│ • Second Line of Defense: Phagocytes, NK Cells, Interferons, Complement (MAC),│
│                           Acute Inflammation (PRISH), Fever (Pyrexia)         │
└──────────────────────────────────────┬────────────────────────────────────────┘
                                       ▼ Antigen Presentation (MHC I & II)
┌───────────────────────────────────────────────────────────────────────────────┐
│ ADAPTIVE IMMUNITY (Specific / Acquired)                                       │
│ • Humoral (Antibody-Mediated): B Lymphocytes -> Plasma Cells -> Antibodies   │
│                                (IgG, IgA, IgM, IgE, IgD) & Memory B Cells     │
│ • Cellular (Cell-Mediated):    T Lymphocytes -> CD4+ Helper T (Th1, Th2) &   │
│                                CD8+ Cytotoxic T Cells (Perforin/Granzymes)    │
└───────────────────────────────────────────────────────────────────────────────┘

2. Innate Immunity: First & Second Lines of Defense

The First Line of Defense: Physical & Chemical Surface Barriers

The body's first line of defense consists of external anatomical and biochemical barriers that physically block, neutralize, or wash away pathogens before they penetrate living tissues:

• Intact Cutaneous Epidermis: Keratinized stratified squamous epithelium forms a tough, waterproof, physical wall impervious to most microorganisms. Continuous sloughing of dead stratum corneum squames sheds adherent microbes.
• The Acid Mantle & Cutaneous Lipids: Sebaceous glands secrete sebum containing antibacterial unsaturated fatty acids (e.g., lauric acid). Sweat glands produce lactic acid, creating an acidic surface environment (pH 4.5 to 5.5) that inhibits bacterial proliferation.
• Mucous Membranes: Non-keratinized epithelial linings of the digestive, respiratory, and urogenital tracts produce thick, viscous mucus that physically entraps inhaled or ingested particulate matter.
• The Mucociliary Escalator: In the respiratory tract, ciliated pseudostratified columnar epithelial cells beat in synchronous rhythm (1,000 beats/minute) to sweep mucus-entrapped pathogens upward away from pulmonary alveoli toward the pharynx to be swallowed or expectorated.
• Biochemical Secretions:
  • Lysozyme: An antimicrobial enzyme found abundantly in tears, saliva, nasal secretions, and perspiration that enzymatically hydrolyzes the peptidoglycan cell walls of Gram-positive bacteria.
  • Gastric Hydrochloric Acid ($HCl$): Gastric juice exhibits an extreme acidity (pH 1.5 to 2.0) combined with the proteolytic enzyme pepsin, destroying the vast majority of swallowed pathogens.
  • Vaginal Acid: Lactic acid produced by symbiotic Lactobacillus species maintains a protective acidic vaginal pH (3.8–4.5).

The Second Line of Defense: Internal Non-Specific Defenses

When microbes breach surface barriers, internal innate defenses immediately deploy to contain and eradicate the invasion:

1. Phagocytes (Neutrophils & Macrophages):
   • Neutrophils: First cellular responders to acute bacterial infection. They extravasate into tissue spaces via diapedesis, engulfing bacteria and destroying them via a respiratory burst (generating reactive oxygen species: superoxide anions, hydrogen peroxide, and hypochlorite).
   • Macrophages: Derived from circulating blood monocytes that migrate into tissues and enlarge. Act as voracious, long-lived phagocytes (free macrophages wander through tissues; fixed macrophages remain anchored, such as Kupffer cells in the liver, microglia in the CNS, and alveolar macrophages in the lungs).
   • Stages of Phagocytosis: Chemotaxis (directional migration) -> Adherence (facilitated by opsonization, where complement proteins or antibodies coat the microbe) -> Ingestion (pseudopodia enclose microbe into a phagosome) -> Digestion (phagosome fuses with a lysosome to form a phagolysosome, where acid hydrolases digest the target) -> Exocytosis of indigestible residual bodies.
2. Natural Killer (NK) Cells:
   • Large granular lymphocytes of innate immunity that patrol the bloodstream and secondary lymphoid organs.
   • Unlike cytotoxic T cells, NK cells do not require specific antigen presentation. Instead, they operate via the "missing-self" hypothesis: healthy somatic cells express surface MHC Class I molecules, which engage inhibitory receptors on NK cells. When a host cell is infected by a virus or undergoes malignant transformation, it frequently downregulates MHC Class I expression.
   • Relieved of inhibition, the NK cell docks to the abnormal target and discharges cytotoxic granules containing perforin (a pore-forming protein that punches transmembrane holes in the target membrane) and granzymes (serine proteases that enter through perforin pores to trigger caspase cascades, executing apoptotic cell suicide).
3. Antimicrobial Proteins: Interferons & The Complement System:
   • Interferons (IFN-$\alpha$, IFN-$\beta$, IFN-$\gamma$): Small signaling cytokines synthesized and released by virally infected host cells. Interferons diffuse to neighboring uninfected cells, binding to surface receptors to induce the transcription of Antiviral Proteins (AVPs) (such as oligoadenylate synthetase and protein kinase R). These AVPs block viral protein translation and degrade viral mRNA, arresting viral replication. IFN-$\gamma$ also powerfully activates macrophages and NK cells.
   • The Complement System: A cascade of over 30 soluble plasma proteins synthesized by the liver that circulate as inactive zymogens. Complement is activated via three initiating pathways:
     • Classical Pathway: Triggered when antibodies ($IgG$ or $IgM$) bind to antigens on a microbial surface.
     • Lectin Pathway: Triggered when serum mannose-binding lectin (MBL) binds to mannose carbohydrates on microbial walls.
     • Alternative Pathway: Triggered by direct spontaneous interaction between complement factors ($B, D, P$) and polysaccharides on foreign bacterial surfaces.
     • Convergence & Defense Outcomes: All pathways converge at the cleavage of C3 into C3a and C3b:
       • Opsonization: C3b binds covalently to bacterial membranes, acting as an "opsonin" that enhances phagocytosis by neutrophils and macrophages.
       • Inflammation & Chemotaxis: C3a and C5a stimulate mast cells and basophils to release histamine, enhancing vascular permeability and attracting neutrophils via chemotaxis.
       • Lysis via MAC Assembly: C5b recruits factors C6, C7, C8, and multiple molecules of C9 to assemble a cylindrical transmembrane pore called the Membrane Attack Complex (MAC). The MAC creates large hydrophilic pores in the bacterial cell membrane, allowing massive influx of water and ions, inducing rapid osmotic lysis.
4. Acute Inflammation:
   • A localized physiological protective response to tissue injury, infection, or trauma. Its goal is to neutralize pathogens, clear cellular debris, and initiate structural repair.
   • The Five Cardinal Signs of Inflammation (PRISH):
     • Pain (Dolor): Resulting from physical distension of nerve endings by inflammatory exudate and direct chemical stimulation of nociceptors by bradykinin and prostaglandins.
     • Redness / Erythema (Rubor): Caused by arteriolar vasodilation and localized hyperemia mediated by histamine, nitric oxide, and leukotrienes.
     • Immobility / Loss of Function (Functio Laesa): Due to pain, structural tissue damage, and mechanical joint restriction from swelling.
     • Swelling / Edema (Tumor): Driven by increased capillary permeability, allowing protein-rich fluid (exudate) to pour from post-capillary venules into interstitial spaces.
     • Heat / Warmth (Calor): Caused by increased arterial blood flow carrying core thermal energy to superficial tissues.
5. Fever (Pyrexia):
   • An orchestrated, systemic elevation in core body temperature above the normal setpoint of 37°C (98.6°F).
   • Pathogenesis: Systemic infection triggers macrophages to release endogenous pyrogens (principally interleukin-1 [IL-1], tumor necrosis factor-alpha [TNF-$\alpha$], and interleukin-6 [IL-6]). Pyrogens stimulate vascular pericytes in the preoptic area of the hypothalamus to synthesize prostaglandin E2 ($PGE_2$), resetting the hypothalamic thermostat upward.
   • Adaptive Benefits: Moderate fever accelerates leukocyte metabolic rates, enhances interferon activity, speeds tissue repair, and causes the liver and spleen to sequester iron and zinc—trace nutrients essential for bacterial enzymatic replication, starving invading microbes.

3. Adaptive Immunity: Antigens, MHC & Clonal Selection

Unlike innate defenses, adaptive immunity exhibits absolute antigen specificity, self/non-self discrimination, and long-term immunological memory. It relies on the interaction between foreign antigens and antigen-specific receptors on lymphocytes:

Antigens & Haptens

• Antigen (Ag): Any substance capable of mobilizing adaptive defenses and provoking an immune response. Complete antigens possess two critical functional properties:
  1. Immunogenicity: The ability to stimulate specific lymphocytes and antibody production.
  2. Reactivity: The ability to react specifically with activated lymphocytes and secreted antibodies.
• Epitope (Antigenic Determinant): The specific, localized three-dimensional molecular domain on an antigen that directly binds to a B-cell receptor, T-cell receptor, or antibody. A single large protein molecule may possess dozens of distinct epitopes.
• Hapten (Incomplete Antigen): A small molecule that possesses reactivity but lacks immunogenicity on its own (e.g., small peptides, synthetic drugs like penicillin, chemicals in cosmetics, urushiol in poison ivy). A hapten cannot trigger an immune response alone; however, if it chemically conjugates with a large endogenous "carrier" host protein, the immune system recognizes the complex as foreign, launching an attack that can precipitate severe contact dermatitis or systemic drug allergies.

Major Histocompatibility Complex (MHC) & Antigen Presentation

T lymphocytes cannot recognize free, soluble antigens floating in solution; they can only recognize antigen fragments that are physically processed and presented on host cell surfaces bound to specialized glycoproteins called Major Histocompatibility Complex (MHC) molecules (known in humans as Human Leukocyte Antigens [HLA]):

MHC Antigen Presentation Dichotomy:
┌───────────────────────────────────────────────┬───────────────────────────────────────────────┐
│ MHC Class I Molecules                         │ MHC Class II Molecules                        │
├───────────────────────────────────────────────┼───────────────────────────────────────────────┤
│ Distribution: On ALL nucleated somatic cells  │ Distribution: ONLY on Professional APCs       │
│ (Absent on anucleate mature erythrocytes).    │ (Dendritic cells, Macrophages, B cells).      │
├───────────────────────────────────────────────┼───────────────────────────────────────────────┤
│ Antigen Source: Endogenous antigens           │ Antigen Source: Exogenous antigens            │
│ (Synthesized within cell: viruses, tumors).   │ (Phagocytosed/ingested from extracellular).   │
├───────────────────────────────────────────────┼───────────────────────────────────────────────┤
│ Recognized By: CD8+ Cytotoxic T Lymphocytes   │ Recognized By: CD4+ Helper T Lymphocytes      │
│ (Rule of 8: MHC I x CD8 = 8)                  │ (Rule of 8: MHC II x CD4 = 8)                 │
└───────────────────────────────────────────────┴───────────────────────────────────────────────┘

4. Humoral Immunity: B Cells, Antibodies & Active vs. Passive Protection

Humoral immunity (antibody-mediated immunity) is mediated by circulating antibodies synthesized and secreted by the B-lymphocyte lineage, protecting against extracellular bacteria, bacterial toxins, and circulating viruses.

B-Cell Activation & Clonal Selection

1. Antigen Binding: A naive B lymphocyte encounters its cognate, unprocessed antigen in a lymph node or splenic follicle. The antigen binds directly to membrane-bound B-cell receptors (BCRs, which are membrane-bound monomeric IgM and IgD antibodies).
2. T-Cell Help: The B cell internalizes the antigen-receptor complex via receptor-mediated endocytosis, degrades it, and displays antigenic peptides on its surface bound to MHC Class II molecules. A sensitized CD4+ Helper T cell recognizes the MHC-II-peptide complex, docking and secreting cytokines (principally interleukin-4 [IL-4] and IL-5).
3. Clonal Selection & Proliferation: Cytokines drive the B cell into rapid mitotic division, producing an identical clone pool:
   • Plasma Cells: The vast majority of cloned B cells differentiate into short-lived plasma cells (surviving 4 to 5 days). A single plasma cell operates as a high-volume antibody factory, synthesizing and secreting up to 2,000 antibody molecules per second into the bloodstream and lymph.
   • Memory B Cells: A fraction of the cloned cells differentiate into long-lived memory B cells, persisting in secondary lymphoid tissues for decades to mediate rapid anamnestic responses upon subsequent re-exposure.

Antibody Architecture & The Five Immunoglobulin Classes

An antibody (immunoglobulin, Ig) is a Y-shaped soluble glycoprotein tetramer composed of four polypeptide chains connected by covalent disulfide bonds: two identical heavy (H) chains (~450 amino acids) and two identical light (L) chains (~220 amino acids):

• Variable (V) Regions: Located at the tips of the "Y" arms. The variable regions of one heavy and one light chain fold together to form an antigen-binding site (Fab fragment). Each antibody monomer possesses two identical Fab sites (bivalent).
• Constant (C) Regions: Located in the stem of the "Y" (Fc fragment). The constant region is identical across antibodies of the same class, determining the biological effector functions (complement fixation, placental transfer, mast cell docking).

Antibody (Immunoglobulin) Structural Diagram:
         Fab Fragments (Antigen-Binding Sites)
         \   /                         \   /
          \ /                           \ /
           V                             V
          [Variable Region: Hypervariable antigen binding]
          ────────────────────────────────────────────────
          [Constant Region: Fc Stem - Biological Effect]
                          │       │
                          │       │  (Heavy Chains)
                          │       │
                          └───────┘

5. Cellular Immunity: T-Cell Subsets & Effector Mechanisms

While humoral immunity targets pathogens circulating freely in extracellular fluids, cellular (cell-mediated) immunity is specialized for eliminating intracellular pathogens (viruses, Chlamydia, Listeria), foreign tissue grafts, and mutated cancer cells that hide within host cells beyond the reach of circulating antibodies.

T-Lymphocyte Activation & Effector Subsets:
Naive CD4+ T Cell + MHC-II (on APC)  ──>  CD4+ Helper T Cells (Th1, Th2)
                                           │ (Secrete cytokines: IL-2, IL-4, IFN-gamma)
                                           ├─────────────────────────────────────────┐
                                           ▼                                         ▼
Naive CD8+ T Cell + MHC-I (on Somatic) ──> CD8+ Cytotoxic T Cells (CTLs)   B-Cell Activation
                                           │ (Perforin, Granzymes, FasL)     (Plasma Cells)
                                           ▼
                                   Target Host Cell Apoptosis

CD4+ Helper T Lymphocytes ($T_h$)

Helper T cells ($T_h$) are the central orchestrators of all adaptive immune responses. Without helper T cells, neither effective humoral nor cytotoxic cell-mediated immunity can function (as evidenced by the catastrophic immunodeficiency seen in untreated HIV infection, which selectively infects and destroys CD4+ T cells via surface CD4 and CCR5/CXCR4 receptors):

• Activation: A naive CD4+ T cell recognizes an exogenous peptide displayed on MHC Class II of an antigen-presenting cell. Coreceptor CD4 binds to the lateral domain of MHC-II, and a secondary costimulatory signal (such as B7 on the APC binding CD28 on the T cell) confirms activation.
• Effector Subsets:
  • $Th_1$ Cells: Secrete interleukin-2 (IL-2) and interferon-gamma (IFN-$\gamma$). Drive cellular immunity by stimulating the clonal proliferation of CD8+ cytotoxic T cells, activating NK cells, and transforming macrophages into voracious "killer macrophages".
  • $Th_2$ Cells: Secrete interleukin-4 (IL-4), IL-5, and IL-13. Drive humoral immunity by activating B cells into antibody-secreting plasma cells, stimulating antibody class-switching to IgE, and activating eosinophils for parasite defense.

CD8+ Cytotoxic T Lymphocytes ($T_c$ / CTLs)

Cytotoxic T cells ($T_c$) are the direct killer cells of adaptive immunity, specialized in seeking out and destroying virally infected somatic cells, intracellularly parasitized cells, and cancer cells:

• Activation & Docking: A naive CD8+ T cell recognizes an endogenous viral or neoplastic peptide presented on MHC Class I of an infected host cell, stabilized by the CD8 coreceptor. Costimulatory cytokines (chiefly IL-2 from $Th_1$ cells) drive the CD8+ cell to proliferate into active CTLs.
• The Lethal Hit Mechanisms:
  1. Perforin / Granzyme Pathway: The CTL docks tightly with the target cell, forming an immunological synapse. It exocytoses granules containing perforin, which polymerizes in the target cell membrane to punch open cylindrical pores. The CTL then injects granzymes (serine proteases) through these pores. Granzymes cleave and activate intracellular caspases, activating target cell endonucleases that fragment host DNA and induce apoptotic cell suicide.
  2. Fas Ligand (FasL) Pathway: The CTL expresses surface Fas ligand (FasL), which binds to death receptor Fas (CD95) on the target cell membrane, directly triggering apoptosis.
• Target Cell Lysis: In both pathways, the dying cell shrivels cleanly into apoptotic bodies without releasing its toxic intracellular contents, and is consumed by macrophages. The CTL detaches unharmed and continues hunting for additional infected cells.

Regulatory T Lymphocytes ($T_{reg}$)

Regulatory T cells ($T_{reg}$) are a specialized subset of CD4+ T lymphocytes expressing the interleukin-2 receptor alpha chain (CD25) and the master regulatory transcription factor FoxP3:

• Function: $T_{reg}$ cells downregulate immune responses after a pathogen has been cleared, and act as the principal guardians of peripheral self-tolerance.
• Mechanism: They secrete inhibitory, immunosuppressive cytokines—predominantly transforming growth factor-beta (TGF-$\beta$) and interleukin-10 (IL-10)—which directly suppress the activation and proliferation of self-reactive B and T lymphocytes, preventing autoimmune disease.

Active vs. Passive Immunity Matrix

Adaptive immunity is acquired through either active synthesis of defenses or passive transfer of preformed antibodies:

6. Pathologies of the Lymphatic & Immune Systems

Therapists and bodywork practitioners routinely care for clients presenting with primary and secondary immune and lymphatic disorders. Recognizing the pathological mechanisms and clinical manifestations of these diseases is critical for safe practice and identifying absolute contraindications:

Lymphatic Pathologies Severity Spectrum:
• Lymphedema         -> Protein-rich interstitial pooling due to lymphatic obstruction
• Lymphadenitis      -> Acute regional node infection (soft, tender, enlarged, mobile)
• Lymphangitis       -> Red linear tracking streaks; urgent medical referral (sepsis risk)
• Lymphomas          -> Malignancies of lymphoid tissue (Hodgkin's vs Non-Hodgkin's)
• Mononucleosis      -> EBV infection, B-cell proliferation, severe splenomegaly (rupture hazard)
• Hypersensitivities -> Type I (IgE anaphylaxis) to Type IV (delayed cell-mediated)

1. Lymphedema

Lymphedema is a chronic, progressive condition characterized by the abnormal interstitial accumulation of high-protein fluid resulting from mechanical impairment of lymphatic transport, culminating in soft-tissue swelling, chronic inflammation, adipose hypertrophy, and progressive tissue fibrosis:

• Etiology:
  • Primary Lymphedema: Caused by congenital genetic malformations or hypoplasia/aplasia of lymphatic vessels (e.g., Milroy's disease [congenital], Lymphedema praecox [onset at puberty], Lymphedema tarda [onset after age 35]).
  • Secondary (Acquired) Lymphedema: Caused by extrinsic damage to or obstruction of healthy lymphatic pathways. Globally, the leading cause is lymphatic filariasis (elephantiasis), a mosquito-borne parasitic nematode (Wuchereria bancrofti) infection that occludes collecting trunks. In industrialized nations, secondary lymphedema is predominantly an iatrogenic consequence of cancer therapy—most notably axillary lymph node dissection and radiation therapy following breast cancer, or pelvic lymphadenectomy following gynecological/prostatic cancers.
• Clinical Staging (ISL Staging System):
  • Stage 0 (Latent / Subclinical): Lymph transport capacity is impaired, but no visible swelling is present; client reports heaviness or tightness.
  • Stage 1 (Reversible): Pitting edema that temporarily subsides with overnight limb elevation; minimal tissue fibrosis.
  • Stage 2 (Spontaneously Irreversible): Non-pitting edema that does not resolve with elevation; marked subcutaneous fibro-sclerosis, frequent secondary bacterial cellulitis.
  • Stage 3 (Lymphostatic Elephantiasis): Extreme disfiguring swelling, complete absence of pitting, extensive skin thickening, hyperkeratosis, papillomatous growths, and chronic ulcerations.
• Management: Complete Decongestive Therapy (CDT): The international gold standard of conservative management, comprising Manual Lymphatic Drainage (Vodder technique), multi-layered short-stretch compression bandaging, meticulous cutaneous hygiene (preventing cellulitis), and remedial exercise.
• Therapist Safety Rules:
  • Absolute Contraindication: Never place a blood pressure cuff, perform venipuncture, or apply deep compressive tissue techniques on an affected or at-risk limb. Elevated hydrostatic pressure precipitates acute microvascular leakage that rapidly overwhelms damaged lymphatics, causing irreversible fibro-sclerosis.

2. Lymphadenitis vs. Malignant Lymphadenopathy

• Lymphadenitis: Acute inflammatory enlargement of a lymph node secondary to an infectious process draining through its basin (e.g., streptococcal pharyngitis causing cervical adenitis). Nodes are typically enlarged, soft-to-firm, warm, exquisitely tender, and freely movable within surrounding tissues. Local massage over an active, tender node is strictly contraindicated.
• Malignant Lymphadenopathy: Neoplastic infiltration of a lymph node by metastatic carcinoma cells or primary lymphoma. Nodes present as stony-hard, painless, non-tender, asymmetrical, and fixed (matted) to underlying muscle or overlying skin. Discovered instances mandate immediate physician evaluation.

3. Lymphangitis

Lymphangitis is an acute bacterial infection of lymphatic collecting vessels, most commonly caused by Streptococcus pyogenes (Group A Strep) or Staphylococcus aureus entering through a cutaneous scratch, ulcer, or fungal fissure:

• Clinical Manifestations: Characterized by fine, red, erythematous linear streaks tracking proximally along the skin toward regional lymph node basins (e.g., tracking up the forearm toward the axilla). The streaks are warm, indurated, and tender, accompanied by high fever, chills, diaphoresis, and tachycardia.
• Therapist Safety Protocol: Acute lymphangitis represents an absolute systemic contraindication to all massage therapy, bodywork, and heat applications. The acute infection may already be spreading and can progress to sepsis; massage or heat delays urgent assessment and can worsen pain and inflammation. The therapist must immediately halt treatment and direct the client to emergency medical care for intravenous antibiotics.

4. Malignant Lymphomas

Lymphomas are primary malignant neoplasms originating from lymphocytes and their precursors within lymphoid tissues:

• Hodgkin's Lymphoma (Hodgkin Disease): Accounts for ~10–15% of lymphomas, featuring a bimodal age distribution (peaks at 15–35 years and >55 years). Histologically characterized by the pathognomonic presence of giant, multinucleated, neoplastic B cells called Reed-Sternberg cells (displaying a prominent "owl-eyed" binucleated appearance). Presents as painless, firm, rubbery, movable lymphadenopathy, predominantly in the cervical, supraclavicular, or mediastinal regions, accompanied by systemic "B symptoms" (fever, drenching night sweats, unexplained weight loss). Displays a predictable, orderly nodal spread and high cure rates (>85%).
• Non-Hodgkin's Lymphoma (NHL): A diverse, heterogeneous group of lymphoid malignancies (>85% originating from B cells, remainder from T or NK cells) that lack Reed-Sternberg cells. Tends to occur in older adults (>65 years) and immunocompromised individuals; characterized by widespread, unpredictable, non-contiguous dissemination involving multiple peripheral node basins and extranodal visceral sites (GI tract, liver, bone marrow, CNS).

5. Infectious Mononucleosis (Glandular Fever)

An acute infectious syndrome caused by the Epstein-Barr Virus (EBV), a human herpesvirus (HHV-4) transmitted primarily via saliva ("the kissing disease"):

• Pathophysiology: EBV selectively infects B lymphocytes via surface CD21 receptors. Infected B cells proliferate uncontrollably, prompting a vigorous cytotoxic T-cell response. Circulating blood exhibits an abundance of large, atypical lymphocytes with indented, basophilic cytoplasm (reactive Downey T cells).
• Clinical Triad: High fever, severe exudative pharyngitis, and massive cervical lymphadenopathy, accompanied by profound debilitating fatigue.
• Splenic Involvement & Therapist Contraindication: EBV infection induces acute splenomegaly (splenic enlargement) in up to 50–75% of patients. Cellular infiltration thins and stretches the splenic capsule, leaving the enlarged organ exceptionally fragile. Splenic rupture represents the leading cause of mortality in mononucleosis, capable of occurring spontaneously or following minor abdominal trauma. Absolute Contraindication: Deep abdominal massage, palpation, and athletic contact sports are strictly and absolutely contraindicated for a minimum of 4 to 6 weeks following disease onset due to the catastrophic risk of fatal internal hemorrhage.

7. Hypersensitivities & Autoimmune Disorders

Hypersensitivity Reactions (The Gell & Coombs Classification)

Hypersensitivities are excessive, inappropriate, or deleterious immune responses against harmless environmental antigens (allergens) that inflict host tissue damage:

Gell & Coombs Hypersensitivity Taxonomy (Mnemonic: "ACID"):
• Type I:   Anaphylactic / Allergic (IgE-mediated, immediate mast cell degranulation)
• Type II:  Cytotoxic / Antibody-dependent (IgG/IgM directed against cell surfaces)
• Type III: Immune Complex-mediated (Soluble Ag-Ab complexes deposited in tissues)
• Type IV:  Delayed-Type / Cell-Mediated (T cells & macrophages, 24–72h onset)

Autoimmune Diseases

Autoimmunity represents a catastrophic breakdown in central or peripheral self-tolerance, wherein the immune system recognizes self-antigens as foreign and mounts destructive humoral or cellular attacks against host tissues:

• Mechanisms: Molecular mimicry (cross-reactive microbial antigens resembling host molecules), emergence of hidden/sequestered antigens (e.g., following ocular trauma), genetic susceptibility (specific HLA alleles), and impaired regulatory T-cell ($T_{reg}$) suppression.
• Representative Autoimmune Disorders:
  • Systemic Lupus Erythematosus (SLE): Autoantibodies directed against ubiquitous nuclear antigens (antinuclear antibodies [ANAs], anti-dsDNA), producing widespread Type III immune complex vasculitis, glomerulonephritis, arthritis, and a classic facial butterfly (malar) rash.
  • Rheumatoid Arthritis (RA): Autoimmune destruction of synovial membranes in diarthrodial joints mediated by rheumatoid factor (IgM anti-IgG autoantibodies) and inflammatory cytokines (TNF-$\alpha$, IL-1), producing pannus formation, cartilage erosion, and joint ankylosis.
  • Multiple Sclerosis (MS): Autoreactive T lymphocytes and macrophages infiltrate the central nervous system, destroying the myelin sheath of oligodendrocytes, impairing axonal conduction and causing progressive motor, sensory, and cognitive deficits.
  • Type 1 Diabetes Mellitus: Autoreactive CD8+ cytotoxic T cells selectively destroy insulin-producing beta cells in the pancreatic islets of Langerhans, causing absolute insulin deficiency.
• Therapist Considerations in Autoimmunity:
  • During acute inflammatory exacerbations (flare-ups), vigorous, deep, or stimulating bodywork is strictly contraindicated, as mechanical stimulation elevates circulating inflammatory cytokines and worsens symptoms.
  • During periods of stable remission, gentle, supportive, parasympathetic-inducing bodywork is clinically indicated to alleviate chronic muscular guarding, reduce stress, and improve quality of life.